7-Benzylidenenaltrexone (BNTX), a highly selective δ1 antagonist, the first clear evidence for δ receptor subtypes based on binding

M. Sultana, A. E. Takemori, P. S. Portoghese

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Number of pages1
JournalNIDA Research Monograph Series
Issue number132
StatePublished - Jan 1 1993

Cite this